8 HCW BIOLOGICS

Serial Number 97033411
Registration 7021996
700

Registration Progress

Application Filed
Sep 17, 2021
Under Examination
Approved for Publication
Jan 24, 2023
Published for Opposition
Jan 24, 2023
Registered
Apr 11, 2023

Trademark Image

8 HCW BIOLOGICS

Basic Information

Serial Number
97033411
Registration Number
7021996
Filing Date
September 17, 2021
Registration Date
April 11, 2023
Published for Opposition
January 24, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 11, 2023
Registration
Registered
Classes
042

Rights Holder

HCW Biologics Inc.

03
Address
2929 N Commerce Pkwy
Miramar, FL 33025

Ownership History

HCW Biologics Inc.

Original Applicant
03
Miramar, FL

HCW Biologics Inc.

Owner at Publication
03
Miramar, FL

HCW Biologics Inc.

Original Registrant
03
Miramar, FL

Legal Representation

Attorney
Cynthia J. Walden

USPTO Deadlines

Next Deadline
1182 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230411)
Due Date
April 11, 2029
Grace Period Ends
October 11, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Apr 11, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 11, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 22, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 22, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 22, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 22, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 22, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 23, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 23, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 23, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 21, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 28, 2021 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Oct 28, 2021 ALIE A ASSIGNED TO LIE Loading...
Oct 5, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Oct 23, 2021 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 21, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Development of platform technology, namely, immunotherapy pharmaceutical platforms for use in manufacturing therapeutics related to inflammaging, inflammatory diseases, age-related diseases and cancer; Medical and scientific research and development services in the field of protein therapeutics and immunotherapeutics; pharmaceutical product development; pharmaceutical research and development services; Research and development of pharmaceuticals for the treatment of age-related and inflammatory diseases and cancer
First Use Anywhere: May 28, 2018
First Use in Commerce: May 28, 2018

Additional Information

Design Mark
The mark consists of A figure "8" followed by the letters "H" with an arrow, the letter "C" and the letter "W" with slanted lines separating the two outer strokes from the middle of the letter, with the word "Biologics" underneath the letters "C" and "W".
Pseudo Mark
EIGHT HCW BIOLOGICS

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOLOGICS"